Get started
Author

Sharon Bergeron

Observed names: S BERGERON, S Bergeron
OpenAlex ID: A5032957928
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance
2017 · Laura B. Ramsey, Frank M. Balis, et al. · The Oncologist · 228
PDF
Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children’s Oncology Group report
2012 · S Goldman, L Smith, et al. · Leukemia · 163
Chromosome Abnormalities May Correlate With Prognosis in Burkitt/Burkitt-Like Lymphomas of Children and Adolescents
2004 · Mark A. Lones, Warren G. Sanger, et al. · Journal of Pediatric Hematology/Oncology · 60
Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08
2006 · Mark A. Lones, Nyla A. Heerema, et al. · Cancer Genetics and Cytogenetics · 57
Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
2017 · Van Thu Huynh, Sharon Bergeron · Clinical journal of oncology nursing · 43
Dinutuximab
2016 · Joy Bartholomew, Tanea Washington, et al. · Journal of Pediatric Oncology Nursing · 19
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.
2001 · F Bracho, M D Krailo, et al. · PubMed · 17
Empowering Adolescents and Young Adults to Support, Lead, and Thrive: Development and Validation of an AYA Oncology Child Life Program
2019 · Sharon Bergeron, Kara Noskoff, et al. · Journal of Pediatric Nursing · 16
A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group.
1998 · M S Cairo, M D Krailo, et al. · PubMed · 10
A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors
1998 · Mitchell S. Cairo, Mark D. Krailo, et al. · Cancer · 10
PDF
Assessing Immunoglobulin Heavy Chain Rearrangements in Pediatric CD20-Positive and CD20-Negative Classic Hodgkin's Diseas
2004 · Bruce Shiramizu, Sherrie L. Perkins, et al. · Clinical Lymphoma · 2
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.
2021 · Katherine Tarlock, Xiaowei Liu, et al. · Journal of Clinical Oncology
A Review of the Past, Present, and Future Clinical Trials From The Children's Cancer Group
1998 · S BERGERON · Journal of Pediatric Oncology Nursing
Works count: 13
Citation count: 625
H-index: 10
I10-index: 10
Year
Topic
Type